Target intelligence / Profile preview

Gametocyte transmission processes

Molecular classification
Other
01

Overview

Gametocyte transmission processes refer to the biological stages of the malaria parasite (Plasmodium spp.) that enable its spread from humans to mosquito vectors. This process begins with gametocytogenesis, where asexual parasites differentiate into sexual forms (gametocytes) that mature over several days (Josling et al., 2018). These mature gametocytes are the only stage capable of surviving ingestion by an Anopheles mosquito and initiating the mosquito-stage of the life cycle, including fertilization and ookinete formation (Bousema & Drakeley, 2011). Targeting these processes is a critical component of malaria elimination strategies, as it aims to break the cycle of infection within a community. While most antimalarial drugs target the symptomatic asexual stages, specific agents like primaquine and methylene blue are effective against mature gametocytes, thereby reducing transmission potential (WHO, 2023). Challenges in targeting these processes include the metabolic quiescence of mature gametocytes and the ethical consideration that transmission-blocking interventions primarily benefit the community rather than the individual patient. Furthermore, the development of transmission-blocking vaccines (TBVs) targeting surface proteins like Pfs25 represents a parallel approach to interrupting these processes.

Other names
GametocytogenesisMalaria transmission cycleSexual stage developmentTransmission-blocking activity
02

Mechanism of action

Inhibition of the differentiation, maturation, or viability of Plasmodium gametocytes, or the prevention of their fertilization and development within the mosquito vector (Bousema & Drakeley, 2011).

03

Biological functions

Cell differentiationReproductionHost-pathogen interactionParasite transmission
04

Disease associations

InfectionMalaria
05

Safety considerations

Hemolysis in G6PD-deficient patients (associated with 8-aminoquinolines)Lack of direct clinical benefit to the individual patient (altruistic nature)Potential for selection of resistant parasite strains
06

Interacting drugs

Primaquine

6 more in the full profile.

07

Biomarkers

Gametocyte density (microscopy or qPCR)Pfs25 mRNA expressionStandard Membrane Feeding Assay (SMFA) transmission-blocking activity

Beyond the preview

Go deeper on Gametocyte transmission processes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gametocyte transmission processes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call